Charles Dunham and Nick Diamond are speaking in Today’s Clinical Lab March webinar on “Navigating the FDA’s LDT Final Rule: Legal Challenges and Upcoming Compliance Deadlines Facing the Laboratory Industry.” During this program, attendees will: learn more about the FDA’s history of LDT oversight with enforcement discretion and targeted Congressional legislation; understand the legal arguments against the FDA’s authority and what the possible outcomes will mean for clinical labs; explore what guidance the FDA has provided to the market about Phase I compliance of the LDT rule in 2025; walk away with operational steps clinical labs can take in an uncertain regulatory environment.